Evaluation of a recombinant tetanus toxin subunit vaccine
| Autor: | Jian-Sheng Lu, Xiaobin Pang, Zhixin Yang, Dan-Yang Shi, Zhi-Ying Li, Wang Rong, Yunzhou Yu, Fu-Jia Liu |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Clostridium tetani
Toxicology medicine.disease_cause complex mixtures Epitope Mice Antigen Tetanus Toxin Gangliosides mental disorders medicine Tetanus Toxoid Animals Humans Mice Inbred BALB C Vaccines Synthetic Tetanus biology Chemistry organic chemicals Immunogenicity Toxoid medicine.disease Virology Antibodies Neutralizing Vaccines Subunit biology.protein Antibody Exotoxin |
| Zdroj: | Toxicon : official journal of the International Society on Toxinology. 187 |
| ISSN: | 1879-3150 |
| Popis: | Tetanus is an acute, fatal disease caused by exotoxin produced by Clostridium tetani. The current vaccine against tetanus is based on inactivated tetanus toxin (TeNT). To develop a recombinant TeNT vaccine suitable for replacement of full-length tetanus toxoid (TT) vaccine for use in humans, a recombinant non-tagged isoform of the Hc domain of the tetanus toxin (THc) was expressed in Escherichia coli and purified by sequential chromatography steps. The immunogenicity and protective effect of the THc antigen were explored and compared with those of TT in Balb/c mice. The THc-based subunit vaccine provided complete protection against TeNT challenge following a high dosage as a toxoid vaccine. While the anti-THc and neutralising antibody titres were higher for the THc-based vaccine than the TT vaccine because protective epitopes are located on the THc domain. Frequency- and dose-dependent immunoprotection were also observed in THc-immunised mice. Mice immunised with one injection of 1 μg or 4 μg THc antigen were completely protected against 102 or 103 50% mouse lethal dose (LD50) of TeNT, respectively. Furthermore, the THc protein was found to recognise and bind to ganglioside GT1b in a dose-dependent manner, and anti-THc sera antibodies also inhibited binding between THc and GT1b. Antigen on the form of recombinant non-tagged THc domain expressed in E. coli achieved strong immunoprotective potency, suggesting that it could be developed into a candidate subunit vaccine against tetanus as an alternative to the current TT vaccine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect